New hope for HS sufferers: Long-Term drug trial launches

NCT ID NCT07007637

First seen Oct 01, 2025 · Last updated May 16, 2026 · Updated 27 times

Summary

This study looks at the long-term safety and effectiveness of a drug called sonelokimab for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. About 835 participants who were in earlier studies will receive the drug as an injection under the skin. The goal is to see if the drug remains safe and helps control symptoms over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Clinical Site

    Birmingham, Alabama, 35244, United States

  • Clinical Site

    North Little Rock, Arkansas, 72117, United States

  • Clinical Site

    Los Angeles, California, 90404, United States

  • Clinical Site

    Northridge, California, 91325, United States

  • Clinical Site

    Aventura, Florida, 33180, United States

  • Clinical Site

    Coral Gables, Florida, 33134, United States

  • Clinical Site

    Hialeah, Florida, 33012, United States

  • Clinical Site

    Hollywood, Florida, 33021-6746, United States

  • Clinical Site

    Miami, Florida, 33136, United States

  • Clinical Site

    Miami, Florida, 33163, United States

  • Clinical Site

    Ocala, Florida, 34471, United States

  • Clinical Site

    Tampa, Florida, 33607, United States

  • Clinical Site

    Tampa, Florida, 33613, United States

  • Clinical Site

    Macon, Georgia, 31217, United States

  • Clinical Site

    Sandy Springs, Georgia, 30328, United States

  • Clinical Site

    Skokie, Illinois, 60077, United States

  • Clinical Site

    West Dundee, Illinois, 60118, United States

  • Clinical Site

    Columbus, Indiana, 47201, United States

  • Clinical Site

    New Albany, Indiana, 47150, United States

  • Clinical Site

    Plainfield, Indiana, 46168, United States

  • Clinical Site

    Louisville, Kentucky, 40241, United States

  • Clinical Site

    Murray, Kentucky, 42071, United States

  • Clinical Site

    Metairie, Louisiana, 70006, United States

  • Clinical Site

    Boston, Massachusetts, 02116, United States

  • Clinical Site

    Boston, Massachusetts, 02215, United States

  • Clinical Site

    Ann Arbor, Michigan, 48109-5314, United States

  • Clinical Site

    Canton, Michigan, 48187, United States

  • Clinical Site

    Clarkston, Michigan, 48346, United States

  • Clinical Site

    Waterford, Michigan, 48328, United States

  • Clinical Site

    New Brighton, Minnesota, 55112, United States

  • Clinical Site

    Omaha, Nebraska, 68144, United States

  • Clinical Site

    Las Vegas, Nevada, 89148, United States

  • Clinical Site

    New York, New York, 10003, United States

  • Clinical Site

    New York, New York, 10012, United States

  • Clinical Site

    The Bronx, New York, 10467, United States

  • Clinical Site

    Fargo, North Dakota, 58103, United States

  • Clinical Site

    Boardman, Ohio, 44512, United States

  • Clinical Site

    Columbus, Ohio, 43213, United States

  • Clinical Site

    Dayton, Ohio, 45324, United States

  • Clinical Site

    Oklahoma City, Oklahoma, 73118, United States

  • Clinical Site

    Murfreesboro, Tennessee, 37130, United States

  • Clinical Site

    Dallas, Texas, 75235, United States

  • Clinical Site

    Dallas, Texas, 75246, United States

  • Clinical Site

    Houston, Texas, 77004, United States

  • Clinical Site

    San Antonio, Texas, 78213, United States

  • Clinical Site

    San Antonio, Texas, 78218, United States

  • Clinical Site

    South Jordan, Utah, 84095, United States

  • Clinical Site

    Mill Creek, Washington, 98012, United States

  • Clinical Site

    Morgantown, West Virginia, 26505, United States

  • Clinical Site

    Ghent, 9000, Belgium

  • Clinical Site

    Leuven, 3000, Belgium

  • Clinical Site

    Pleven, Ontario, 5800, Bulgaria

  • Clinical Site

    Sofia, Ontario, 1463, Bulgaria

  • Clinical Site

    Stara Zagora, Ontario, 6003, Bulgaria

  • Clinical Site

    Sofia, 1407, Bulgaria

  • Clinical Site

    Sofia, 1431, Bulgaria

  • Clinical Site

    Sofia, 1510, Bulgaria

  • Clinical Site

    Sofia, 1606, Bulgaria

  • Clinical Site

    Calgary, Alberta, T3E 0B2, Canada

  • Clinical Site

    Edmonton, Alberta, T6G 1C3, Canada

  • Clinical Site

    Edmonton, Alberta, T6H 4J8, Canada

  • Clinical Site

    Sherwood Park, Alberta, T8H 0P1, Canada

  • Clinical Site

    Winnipeg, Manitoba, R3M 3Z4, Canada

  • Clinical Site

    Fredericton, New Brunswick, E3B 1G9, Canada

  • Clinical Site

    Barrie, Ontario, L4M 7G1, Canada

  • Clinical Site

    Guelph, Ontario, N0B 2J0, Canada

  • Clinical Site

    London, Ontario, N6H 5L5, Canada

  • Clinical Site

    Markham, Ontario, L3P 1X3, Canada

  • Clinical Site

    Newmarket, Ontario, L3Y 5G8, Canada

  • Clinical Site

    Peterborough, Ontario, K9J 5K2, Canada

  • Clinical Site

    Toronto, Ontario, M2N 3A6, Canada

  • Clinical Site

    Toronto, Ontario, M4E 1R7, Canada

  • Clinical Site

    Toronto, Ontario, M5A3R6, Canada

  • Clinical Site

    Montreal, Quebec, H1Y 3L1, Canada

  • Clinical Site

    Québec, Quebec, G1W 4R4, Canada

  • Clinical Site

    Saskatoon, Saskatchewan, S7K 2C1, Canada

  • Clinical Site

    Ostrava, 708 52, Czechia

  • Clinical Site

    Prague, 110 00, Czechia

  • Clinical Site

    Brest, 29200, France

  • Clinical Site

    Lyon, 69003, France

  • Clinical Site

    Saint-Mandé, 94160, France

  • Clinical Site

    Saint-Priest-en-Jarez, 42270, France

  • Clinical Site

    Halle, Saale, 06108, Germany

  • Clinical Site

    Bad Bentheim, 48455, Germany

  • Clinical Site

    Berlin, 10117, Germany

  • Clinical Site

    Berlin, 10789, Germany

  • Clinical Site

    Bielefeld, 33647, Germany

  • Clinical Site

    Bochum, 44791, Germany

  • Clinical Site

    Bochum, 44793, Germany

  • Clinical Site

    Bramsche, 49565, Germany

  • Clinical Site

    Darmstadt, 64283, Germany

  • Clinical Site

    Dresden, 01307, Germany

  • Clinical Site

    Erlangen, 91054, Germany

  • Clinical Site

    Frankfurt, 60590, Germany

  • Clinical Site

    Hanover, 30159, Germany

  • Clinical Site

    Kiel, 24105, Germany

  • Clinical Site

    Langenau, 89129, Germany

  • Clinical Site

    Lübeck, 23538, Germany

  • Clinical Site

    Mahlow, 15831, Germany

  • Clinical Site

    Münster, 48149, Germany

  • Clinical Site

    Wuppertal, 42283, Germany

  • Clinical Site

    Würzburg, 97080, Germany

  • Clinical Site

    Debrecen, 4026, Hungary

  • Clinical Site

    Debrecen, 4032, Hungary

  • Clinical Site

    Pécs, 7632, Hungary

  • Clinical Site

    Chieti, 66013, Italy

  • Clinical Site

    Cona, 44124, Italy

  • Clinical Site

    Milan, 20122, Italy

  • Clinical Site

    Modena, 41126, Italy

  • Clinical Site

    Perugia, 06129, Italy

  • Clinical Site

    Pisa, 56126, Italy

  • Clinical Site

    Roma, 00168, Italy

  • Clinical Site

    Rozzano, 20089, Italy

  • Clinical Site

    Torino, 10126, Italy

  • Clinical Site

    Torrette, 60126, Italy

  • Clinical Site

    Rotterdam, 3015 GD, Netherlands

  • Clinical Site

    Oslo, 0424, Norway

  • Clinical Site

    Bialystok, 15-453, Poland

  • Clinical Site

    Chorzów, 41-516, Poland

  • Clinical Site

    Gdansk, 80-214, Poland

  • Clinical Site

    Katowice, 40-611, Poland

  • Clinical Site

    Kielce, 25-316, Poland

  • Clinical Site

    Krakow, 30-002, Poland

  • Clinical Site

    Krakow, 30-727, Poland

  • Clinical Site

    Lodz, 90-265, Poland

  • Clinical Site

    Lodz, 90-436, Poland

  • Clinical Site

    Lublin, 20-573, Poland

  • Clinical Site

    Ossy, 42-624, Poland

  • Clinical Site

    Poznan, 60-539, Poland

  • Clinical Site

    Poznan, 60-848, Poland

  • Clinical Site

    Sosnowiec, 41-200, Poland

  • Clinical Site

    Szczecin, 70-332, Poland

  • Clinical Site

    Szczecin, 71-270, Poland

  • Clinical Site

    Warsaw, 00-710, Poland

  • Clinical Site

    Warsaw, 02-507, Poland

  • Clinical Site

    Warsaw, 02-692, Poland

  • Clinical Site

    Warsaw, 02-953, Poland

  • Clinical Site

    Wroclaw, 50566, Poland

  • Clinical Site

    Wroclaw, 51-503, Poland

  • Clinical Site

    Lisbon, 1169-050, Portugal

  • Clinical Site

    Lisbon, 1649-035, Portugal

  • Clinical Site

    Trnava, 91775, Slovakia

  • Clinical Site

    Alicante, 03010, Spain

  • Clinical Site

    Badalona, 08916, Spain

  • Clinical Site

    Barcelona, 08003, Spain

  • Clinical Site

    Cadiz, 11009, Spain

  • Clinical Site

    Córdoba, 14004, Spain

  • Clinical Site

    Granada, 18012, Spain

  • Clinical Site

    Granada, 18014, Spain

  • Clinical Site

    Granollers, 08402, Spain

  • Clinical Site

    Madrid, 28006, Spain

  • Clinical Site

    Madrid, 28041, Spain

  • Clinical Site

    Madrid, 28046, Spain

  • Clinical Site

    Manises, 46940, Spain

  • Clinical Site

    Málaga, 29010, Spain

  • Clinical Site

    Santiago de Compostela, 15706, Spain

  • Clinical Site

    Seville, 41009, Spain

  • Clinical Site

    Valencia, 46014, Spain

  • Clinical Site

    Valencia, 46026, Spain

  • Clinical Site

    Salford, M6 8HD, United Kingdom

Conditions

Explore the condition pages connected to this study.